Research Base The MDCTR Research Base includes 69 investigators, 30 from the UM Department of Internal Medicine and 18 from other medical school departments including Pediatrics, Family Medicine, Medical Education, Ophthalmology, Obstetrics and Gynecology, Neurology, Physical Medicine and Rehabilitation, and Urology. Eight investigators come from the School of Public Health, 2 from the School of Social Work, 1 from the School of Nursing, 1 from the School of Dentistry, and 1 from the Institute for Social Research. In addition, 7 come from affiliated Universities and Research Institutes. Research Base investigators are united by their focus on developing, implementing, and evaluating evidence-based approaches to prevent and treat diabetes that can be disseminated and sustained in clinical and community settings outside of the traditional academic research setting. Interventions have been directed at patients, providers, practices, health systems, and communities. They have involved non-traditional study designs, novel measurements, and economic analyses;new intervention strategies, tools, and platforms;and a focus on health disparities, cultural competence, and community-based participatory research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK092926-03
Application #
8546361
Study Section
Special Emphasis Panel (ZDK1-GRB-1)
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-08-31
Support Year
3
Fiscal Year
2013
Total Cost
$141,188
Indirect Cost
$50,392
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Govani, Shail M; Noureldin, Mohamed; Higgins, Peter D R et al. (2018) Defining an Optimal Adherence Threshold for Patients Taking Subcutaneous Anti-TNFs for Inflammatory Bowel Diseases. Am J Gastroenterol 113:276-282
Kuo, Shihchen; Yang, Chun-Ting; Wu, Jin-Shang et al. (2018) Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort study. Diabetes Obes Metab :
Sjoding, Michael W; Hofer, Timothy P; Co, Ivan et al. (2018) Interobserver Reliability of the Berlin ARDS Definition and Strategies to Improve the Reliability of ARDS Diagnosis. Chest 153:361-367
Hedgeman, Elizabeth; Hasson, Rebecca E; Karvonen-Gutierrez, Carrie A et al. (2018) Perceived stress across the midlife: longitudinal changes among a diverse sample of women, the Study of Women's health Across the Nation (SWAN). Womens Midlife Health 4:
Pesch, Megan H; Miller, Alison L; Appugliese, Danielle P et al. (2018) Mothers of Obese Children Use More Direct Imperatives to Restrict Eating. J Nutr Educ Behav 50:403-407.e1
Batch, Bryan C; Goldstein, Karen; Yancy Jr, William S et al. (2018) Outcome by Gender in the Veterans Health Administration Motivating Overweight/Obese Veterans Everywhere Weight Management Program. J Womens Health (Larchmt) 27:32-39
Ge, Chunxi; Zhao, Guisheng; Li, BinBin et al. (2018) Genetic inhibition of PPAR? S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis. Bone 107:1-9
Jaiswal, Mamta; Divers, Jasmin; Pop-Busui, Rodica et al. (2018) Response to Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226-1232. Diabetes Care 41:e37
Lisabeth, Lynda D; Baek, Jonggyu; Morgenstern, Lewis B et al. (2018) Prognosis of Midlife Stroke. J Stroke Cerebrovasc Dis 27:1153-1159
Buras, Eric D; Weatherup, Emily; Wyckoff, Jennifer (2018) Subcutaneous glucagon infusion and continuous glucose monitoring enable effective management of hypoglycemia in a patient with IGF-2-producing hemangiopericytoma. Clin Diabetes Endocrinol 4:2

Showing the most recent 10 out of 592 publications